HCID 58277360, Verbindung → HCID 58277269, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:12]([C:13]3[CH:18]=[C:17]([C:19]([F:22])([F:21])[F:20])[CH:16]=[C:15]([F:23])[CH:14]=3)=[CH:11][C:10]([C:24](O)=[O:25])=[N:9]2)[CH:5]=[CH:6][CH:7]=1.ClC1C=C(N2C(C3C=CC=C(OCCO)C=3)=CC(C([N:51]3[CH2:55][C:54](=[O:56])[NH:53][CH2:52]3)=O)=N2)C=CC=1>C(O)=O>[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:12]([C:13]3[CH:18]=[C:17]([C:19]([F:20])([F:21])[F:22])[CH:16]=[C:15]([F:23])[CH:14]=3)=[CH:11][C:10]([C:24]([N:51]3[CH2:55][C:54](=[O:56])[NH:53][CH2:52]3)=[O:25])=[N:9]2)[CH:5]=[CH:6][CH:7]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
The preparation of the title compound takes place starting from the compound of Example 97A in analogy to the synthesis of the compound of Example 23 with the addition of 0.1% formic acid in the preparative HPLC. 60 mg (51% of theory) of the title compound are obtained.
Quellen und Nachweise
- ORD-Eintrag
- ord-6e8d5a9681094fe8b17b84924db455df
- Quelldatensatz
- uspto-grants-2013_03
- Patentnummer
- US08399682B2
Notizen zur Reaktion
Wird geladen…